Labeeuw
Bernard Labeeuw, Montpellier FR
Patent application number | Description | Published |
---|---|---|
20090156574 | 2-ACYLAMINO-4-PHENYLTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF - The invention relates to 2-acylamino-4-phenylthiazole derivatives of general formula (I): | 06-18-2009 |
Olivier Labeeuw, Rennes FR
Patent application number | Description | Published |
---|---|---|
20090111808 | NOVEL HISTAMINE H3-RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS - The present patent application concerns compounds of formula (I) with R1 and R2 taken together with the nitrogen atom to which they are attached, form a mono or bicyclic saturated nitrogen-containing ring; their preparation and their use as a H3 receptor ligand for treating e.g. CNS disorders like Alzheimer's disease. | 04-30-2009 |
Olivier Labeeuw, Fougeres FR
Patent application number | Description | Published |
---|---|---|
20120129892 | NOVEL PHARMACEUTICALLY ACCEPTABLE SALTS OF 4-(1H-IMIDAZOL-4-YLMETHYL)PYRIDINE AND THEIR THERAPEUTICAL USES - The present invention concerns novel pharmaceutical compositions of immethridine, in particular of novel pharmaceutically acceptable salts thereof, such as the dioxalate salt of immethridine, as well as its therapeutical uses and novel process of preparation. | 05-24-2012 |
20130231329 | Benzazole Derivatives as Histamine H4 Receptor Ligands - The present patent application concerns new ligands of the H4-receptor of formula (I), their process of preparation and their therapeutic use. | 09-05-2013 |
20130324506 | New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands - The present patent application concerns new ligands of the H4-receptor, their process of preparation and their therapeutic use. | 12-05-2013 |
20130324507 | Novel (aza)Benzhydryl Ether Derivatives, Their Process of Preparation and Their Use as H4-Receptor Ligands for Therapeutical Applications - The present invention concerns novel (aza)benzhydryl ether derivatives which exhibit H4-receptor binding activity. The present invention also concerns their process of preparation and their therapeutical uses. | 12-05-2013 |